The optimal surfactant experience should start with efficient administration that is easy on your staff and may improve tolerability for your babies.
Explore 3 ways that you and your patients may benefit from CUROSURF administration.
As the chart below illustrates, with higher surfactant concentration and phospholipid concentration in each dose of CUROSURF, less volume is needed in the baby’s lungs.1-3 Less volume may improve tolerability and has the potential to reduce complications such as airway obstruction.4
Clinical studies have not established that lower volume results in superior efficacy or safety based on clinically relevant end points.
CUROSURF delivers more than twice the phospholipid concentration (mg/mL) of other natural surfactants.1-3
CUROSURF is a thin suspension, which has been shown to spread quickly and evenly.5
CUROSURF quickly forms a stable surfactant monolayer inside the alveoli, giving you the option to suction airways after just 1 hour.1,6
In an observational study, CUROSURF demonstrated relatively quick administration and rapid recovery within 1 minute.7 In addition, CUROSURF demonstrated a low reflux rate, which may improve tolerability and ease of administration.7 It has been suggested that the thin suspension helps to minimize airway and endotracheal tube obstruction and associated complications such as transient hypercapnia.4,7
CUROSURF is a thin suspension that demonstrates a low reflux rate and fast recovery time after administration.1,7
Explore how the efficacy of CUROSURF can help you experience fast RDS success.